Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 784

1.

Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.

Leschek EW, Flor AC, Bryant JC, Jones JV, Barnes KM, Cutler GB Jr.

J Pediatr. 2017 Nov;190:229-235. doi: 10.1016/j.jpeds.2017.07.047.

PMID:
29144249
2.

The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.

Nguyen TV, Reuter JM, Gaikwad NW, Rotroff DM, Kucera HR, Motsinger-Reif A, Smith CP, Nieman LK, Rubinow DR, Kaddurah-Daouk R, Schmidt PJ.

Transl Psychiatry. 2017 Aug 8;7(8):e1193. doi: 10.1038/tp.2017.146.

3.

Effects of testosterone administration (and its 5-alpha-reduction) on parenchymal organ volumes in healthy young men: findings from a dose-response trial.

Gagliano-Jucá T, Tang ER, Bhasin S, Pencina KM, Anderson S, Jara H, Li Z, Melamud K, Coleman SL, Aakil A, Almeida RR, Huang G, Travison TG, Storer TW, Basaria S.

Andrology. 2017 Sep;5(5):889-897. doi: 10.1111/andr.12392. Epub 2017 Jul 13.

PMID:
28704587
4.

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y.

Int J Clin Oncol. 2017 Dec;22(6):1087-1093. doi: 10.1007/s10147-017-1160-8. Epub 2017 Jul 5.

PMID:
28681153
5.

Testicular vs adrenal sources of hydroxy-androgens in prostate cancer.

Zang T, Taplin ME, Tamae D, Xie W, Mesaros C, Zhang Z, Bubley G, Montgomery B, Balk SP, Mostaghel EA, Blair IA, Penning TM.

Endocr Relat Cancer. 2017 Aug;24(8):393-404. doi: 10.1530/ERC-17-0107. Epub 2017 Jun 29.

6.

Acute Testosterone Deficiency Alters Adipose Tissue Fatty Acid Storage.

Santosa S, Bush NC, Jensen MD.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):3056-3064. doi: 10.1210/jc.2017-00757.

7.

Regulation of Pulsatile and Entropic ACTH Secretion Under Fixed Exogenous Secretagogue Clamps.

Roelfsema F, Aoun P, Takahashi PY, Erickson D, Yang R, Veldhuis JD.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2611-2619. doi: 10.1210/jc.2017-00115.

8.
9.

Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.

Liu C, Lu Q, Qu H, Geng L, Bian M, Huang M, Wang H, Zhang Y, Wen Z, Zheng S, Zhang Z.

Medicine (Baltimore). 2017 Feb;96(7):e6124. doi: 10.1097/MD.0000000000006124.

10.

Neoadjuvant Enzalutamide Prior to Prostatectomy.

Montgomery B, Tretiakova MS, Joshua AM, Gleave ME, Fleshner N, Bubley GJ, Mostaghel EA, Chi KN, Lin DW, Sanda M, Novotny W, Wu K, Kantoff PW, Marck BT, Plymate S, Balk SP, Nelson PS, Matsumoto AM, Lis RT, Kibel A, Haas GP, Krivoshik A, Hannah A, Taplin ME.

Clin Cancer Res. 2017 May 1;23(9):2169-2176. doi: 10.1158/1078-0432.CCR-16-1357. Epub 2016 Nov 9.

11.

Efficacy of switching therapy of luteinizing hormone-releasing hormone analogue for advanced prostate cancer.

Shen YC, Kang CH, Chiang PH.

Kaohsiung J Med Sci. 2016 Nov;32(11):567-571. doi: 10.1016/j.kjms.2016.09.005. Epub 2016 Nov 4.

12.

Comparative in vitro release and clinical pharmacokinetics of leuprolide from Luphere 3M Depot, a 3-month release formulation of leuprolide acetate.

Park S, Kim DH, Kim Y, Park JH, Lee M, Song IS, Shim CK.

Drug Dev Ind Pharm. 2017 Mar;43(3):441-447. doi: 10.1080/03639045.2016.1258409. Epub 2016 Nov 22.

PMID:
27824264
13.

A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy.

Sayyid RK, Evans A, Hersey K, Maloni R, Hurtado-Coll A, Kulkarni G, Finelli A, Zlotta AR, Hamilton R, Gleave M, Fleshner NE.

Clin Cancer Res. 2017 Apr 15;23(8):1974-1980. doi: 10.1158/1078-0432.CCR-16-1790. Epub 2016 Oct 18.

14.
16.

A novel approach to administration of peptides in women: Systemic absorption of a GnRH agonist via transvaginal ring delivery system.

Kimball AB, Javorsky E, Ron ES, Crowley W Jr, Langer R.

J Control Release. 2016 Jul 10;233:19-28. doi: 10.1016/j.jconrel.2016.04.035. Epub 2016 Apr 26.

18.

Acute Female Hypogonadism Alters Adipose Tissue Fatty Acid Storage Factors and Chylomicronemia.

Santosa S, Bonnes SL, Jensen MD.

J Clin Endocrinol Metab. 2016 May;101(5):2089-98. doi: 10.1210/jc.2015-4065. Epub 2016 Mar 22.

19.

The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial.

Sadler Gallagher J, Feldman HA, Stokes NA, Laufer MR, Hornstein MD, Gordon CM, DiVasta AD.

J Pediatr Adolesc Gynecol. 2017 Apr;30(2):215-222. doi: 10.1016/j.jpag.2016.02.008. Epub 2016 Feb 27.

20.

Low-dose add-back therapy during postoperative GnRH agonist treatment.

Tsai HW, Wang PH, Huang BS, Twu NF, Yen MS, Chen YJ.

Taiwan J Obstet Gynecol. 2016 Feb;55(1):55-9. doi: 10.1016/j.tjog.2015.04.004.

Supplemental Content

Loading ...
Support Center